News
Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...
The women’s health focused company acquired the drug for up to $954 million in 2021 through the acquisition of Forendo Pharma ...
The high court sides with HHS on HIV PrEP drugs; Health Secretary RFK Jr.’s newly appointed CDC vaccine advisors discuss ...
California’s life sciences manufacturing jobs dipped 3.7% in 2024, according to a new Biocom California report. Still, ...
The safety update for Vyvgart rattled argenx’s shares on Monday, a reaction that analysts at William Blair said was “overdone ...
Kennedy wants to expand the injury compensation program to include COVID-19 vaccines, while also stretching the “statute of ...
As an office of the executive branch, the Department of Health and Human Services “does not have the authority” to implement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results